MS Aug 2024 98.000 call
| Previous close | 3.6800 |
| Open | 5.2000 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 98.00 |
| Expiry date | 2024-08-02 |
| Day's range | 3.3000 - 5.2000 |
| Contract range | N/A |
| Volume | |
| Open interest | 16 |
Investor's Business DailyMorgan Stanley Stock Earns IBD Rating Upgrade
A Relative Strength Rating upgrade for Morgan Stanley shows improving technical performance. Will it continue?
BloombergBicara Therapeutics Picks Morgan Stanley For IPO of Up to $150 Million
(Bloomberg) -- Bicara Therapeutics is working with Morgan Stanley on a US initial public offering, people familiar with the situation said, as the market for first-time share sales is showing signs of normalizing. Most Read from BloombergJustice Department to Charge Boeing, Seeks Guilty Plea from PlanemakerBiden Asks Donors to Stay Following Disastrous DebateBiden's Defiance Has Democrats Fearing They'll Lose White HouseTrump as President or Private Citizen: Why Supreme Court’s Immunity Ruling I
- Business Wire
Morgan Stanley Announces 7.5 Cents Dividend Increase and Authorization of a Renewed $20 Billion Multi-Year Common Equity Share Repurchase Program
NEW YORK, June 28, 2024--Morgan Stanley (NYSE: MS) announced that it will increase its quarterly common stock dividend to $0.925 per share from the current $0.85 per share, beginning with the common stock dividend expected to be declared by the Firm’s Board of Directors in the third quarter of 2024.
